is a compounded tirzepatide safe Tirzepatide: Legal & 2026 Compounded Tirzepatide (GLP-1/GIP)
Description
We will enrol 30 women with obesity and polycystic ovary syndrome (PCOS)
The fountain of youth
In addition, the OB+SMG group received 150 mcg/kg of SMG subcutaneously once a week for the last four weeks
METHODS This retrospective study leveraged TriNetX data (20142024) to identify patients with aSAH, sICH, or AIS
